Scientists investigating the severe developmental disorder known as Rett syndrome have discovered a series of crucial molecular changes that occur long before symptoms appear.
Moderna and Myrtelle among those picked for FDA rare disease programme – Pharmaceutical Technology
The FDA’s pilot programme is set to accelerate the development of novel drug and biological products for rare diseases. Credit: Tada Images via Shutterstock. Moderna
June 6, 2024